Ziccum CEO Analyst video interview: Q1, 2024

(10:)

Ziccum - CEO comment on the most recent Evaluation Agreement

(9:47)

Ziccum - CEO Report Commentary Q2-2023

(9:14)

Eucaps Talks - Interview with Ziccum´s CEO, Ann Gidner

(12:7)

Ziccum | BioStock Life Science Summit 2024

(14:56)

Ziccum | BioStock Global Forum 2024

(14:48)

Panel discussion on mRNA featuring Ziccum´s CEO - Force Family Office Fireside Chat

(36:43)

BioStock Life Science Fall Summit 2022 | Presentation: Ziccum

(16:44)

Ziccum | INTERVIEW | Investing in Life Science 2024

(5:15)

How does Ziccum formulate vaccines as dry powders? Meet Ziccum Project Manager Louise Egeblad

(3:51)

Ziccum | Investing in Life Science 2024

(14:57)

Ziccum Q3 Report Comment

(7:21)

Ziccum: Air-drying biologics: and vaccines

(3:43)

Ziccum - vd intervju Q3 2024

(13:46)

ZICCUM: Safe delivery in all climates

(2:29)

Ziccum - vd intervju Q2 2024

(16:1econd)

Ziccum | BioStock Life Science Spring Summit 2021

(16:58)

Ziccum - Vd-intervju

(8:15)